Cancer BiologybioRxivPreprint
Identification of frequent activating HER2 mutations in primary canine pulmonary adenocarcinoma
Gwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann…·William P. D. Hendricks
This study identifies HER2 mutations in canine pulmonary adenocarcinomas, finding V659E mutations in 38% of cases and their association with drug sensitivity.
DOI 10.1101/528182